Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.394,74
-0,54%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Allogene Therapeutics Inc (ALLO) Allogene Therapeutics Inc (ALLO) Notizie

Allogene Therapeutics Inc

ALLO
2,91
0,055 (1,93%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/4/202414:30GLOBEAllogene Therapeutics Awarded Grant from the California..
09/4/202414:30GLOBEAllogene Therapeutics Announces Q2 Investor Conference..
14/3/202421:05GLOBEAllogene Therapeutics Reports Fourth Quarter and Full Year..
12/3/202413:30GLOBEAllogene Therapeutics and Arbor Biotechnologies Announce..
05/3/202414:30GLOBEAllogene Therapeutics to Report Fourth Quarter and Full Year..
28/2/202414:30GLOBEAllogene Therapeutics Announces Participation in the 44th..
16/2/202414:30EDGAR2Form 8-K - Current report
16/2/202414:30GLOBEAllogene Therapeutics to Restate Previously Filed Financial..
31/1/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:11EDGAR2Form 144 - Report of proposed sale of securities
16/1/202422:05GLOBEAllogene Therapeutics Announces Participation in Upcoming..
05/1/202414:00EDGAR2Form 8-K - Current report
04/1/202422:15GLOBEAllogene Therapeutics and Foresight Diagnostics Announce..
04/1/202422:05GLOBEAllogene Therapeutics Announces 2024 Platform Vision to..
03/1/202422:05GLOBEAllogene Therapeutics to Host Conference Call Previewing its..
20/12/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:46EDGAR2Form 8-K - Current report
18/12/202322:17EDGAR2Form 144 - Report of proposed sale of securities
09/12/202318:00GLOBEAllogene Therapeutics Presents Comprehensive Safety Data of..
01/12/202314:30GLOBEAllogene Therapeutics Announces Participation in December..
03/11/202317:00GLOBEAllogene Therapeutics Presents Preclinical Data on a Novel..
02/11/202321:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/11/202321:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:03EDGAR2Form 8-K - Current report
02/11/202321:02GLOBEAllogene Therapeutics Reports Third Quarter 2023 Financial..
02/11/202314:00GLOBEAllogene Therapeutics Announces Poster Presentations at the..
30/10/202313:30GLOBEAllogene Therapeutics Announces Participation in November..
26/10/202314:30GLOBEAllogene Therapeutics to Report Third Quarter 2023 Financial..
17/10/202322:34EDGAR2Form 8-K/A - Current report: [Amend]
16/10/202314:31EDGAR2Form 8-K - Current report
16/10/202314:30GLOBEAllogene Therapeutics Appoints Geoffrey Parker as Chief..
27/9/202315:09GLOBEAllogene Therapeutics Announces Three Poster Presentations..
05/9/202314:30GLOBEAllogene Therapeutics Announces Participation in September..
15/8/202301:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202301:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202314:30GLOBEAllogene Therapeutics Appoints Earl Douglas as General..
09/8/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202323:15EDGAR2Form 144 - Report of proposed sale of securities
02/8/202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202322:04EDGAR2Form 8-K - Current report
02/8/202322:02GLOBEAllogene Therapeutics Reports Second Quarter 2023 Financial..
26/7/202314:30GLOBEAllogene Therapeutics to Report Second Quarter 2023..
11/7/202312:06VWEthereum Blockchain Game Pikamoon Raises $3.6m, Final ICO..
10/7/202316:44VWMassive Gaming Celebrates Global Launch of House of..
10/7/202311:52VWWOW EARN Wallet Offers One-Stop Shop Features, Now Available..
10/7/202311:02VWSwaap v2 Launches: Revolutionizing DeFi Market Making with..
08/7/202316:03VWBritanniacoin’s Official Pre-release: introducing a unique..
06/7/202317:59VWTether Launches USDt On Kava
06/7/202310:03VWOKX to Launch Signal Trading Platform, Empowering Traders..
Apertura: 2,87 Min: 2,75 Max: 2,93
Chiusura: 2,855

La tua Cronologia

NASDAQ
ALLO
Allogene Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network